To access Ascendiant's recent equity research initiations, please click on the link below. For current reports, or for reports on companies not shown, please contact Edward Woo, Director of Research, at ewoo@ascendiant.com or 949.259.4932.
Atossa Therapeutics, Inc. (NasdaqCM: ATOS) - initiation
Phunware, Inc. (NasdaqGS: PHUN) - initiation
IMAC Holdings, Inc. (NasdaqGS: IMAC) - initiation
SINTX Technologies, Inc. (NasdaqCM: SINT) - initiation
Myomo, Inc. (NYSE American: MYO) - initiation
BioHiTech Global, Inc. (NasdaqCM: BHTG) - initiation
Nemaura Medical, Inc. (NasdaqCM: NMRD) - initiation
Daxor Corporation (NYSE American: DXR) - initiation
Monaker Group, Inc. (NasdaqCM: MKGI) - initiation
Outlook Therapeutics, Inc. (NasdaqCM: OTLK) - initiation
ENDRA Life Sciences, Inc. (NasdaqCM: NDRA) - initiation
FlexShopper, Inc. (NasdaqCM: FPAY) - initiation
Oragenics, Inc. (NYSE American: OGEN) - initiation
Hemispherx Biopharma, Inc. (NYSE American: HEB) - initiation
Summit Wireless Technologies, Inc. (NasdaqCM: WISA) - initiation
ADOMANI, Inc. (NasdaqCM: ADOM) - initiation
MusclePharm Corporation (OTC: MSLP) - initiation
ENSERVCO Corporation (NYSE American: ENSV) - initiation
IsoRay, Inc. (NYSE American: ISR) - initiation
Aemetis, Inc. (NasdaqCM: AMTX) - initiation
ARCA biopharma, Inc. (NasdaqCM: ABIO) - initiation
Novus Therapeutics, Inc. (NasdaqCM: NVUS) - initiation
LRAD Corporation (NasdaqCM: LRAD) - initiation